We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Staying Active in Biotechnology Market
AstraZeneca Staying Active in Biotechnology Market
December 28, 2005
AstraZeneca has agreed to pay up to $1.3 billion under a pair of collaboration agreements to gain access to investigational compounds targeting Alzheimer’s disease and atherosclerosis.